Respiratory Stimulants

Stimulants in Chronic Respiratory Failure

The effects of slow intravenous infusion of three different respiratory stimulants (dimeftine, nikethamide and prethcamide) on minute and alveolar ventilation, blood gases and pH were studied in 18 patients with chronic pulmonary emphysema and chronic respiratory failure. For a more accurate assessment of the results of the double blind controlled trial, a factorial design in a Youden square sc...

Oral Respiratory Stimulants in Chronic Respiratory Failure: Double-blind Controlled Trial of Amiphenazole and Dichlorphenamide.

Pharmaco-epidemiology of Stimulants

tion to treat child and adolescent disorders is causing concern in the community. This particularly applies to the use of stimulants such as amphetamines and methylphenidate. Is the prescription of stimulants restricted to conditions for which they are an effective treatment? Is the medical profession placing too much emphasis on the use of medication to treat childhood mental health problems a...

Stimulants for paediatricians.

D oes your paediatrician have difficulty concentrating during lectures, particularly those on molecular biology and healthcare planning? When taking a history, does your paediatrician not listen properly and keep asking the same questions? Is your paediatrician too busy to spend any time with his or her own children? These are all signs of ADHD(P), a newly described phenotype of attention defic...

Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD.

BACKGROUND Acetazolamide and medroxyprogesterone acetate (MPA) are two respiratory stimulants that can be used in patients with stable hypercapnic COPD. DESIGN AND METHODS The effects of acetazolamide, 250 mg bid, and MPA, 30 mg bid, on daytime and nighttime blood gas values and the influences on the hypercapnic and hypoxic ventilatory and mouth occlusion pressure (P(0.1)) at 100 ms response ...